Impact of Sleep Restriction on Blood Pressure Reactivity
1 other identifier
interventional
45
1 country
1
Brief Summary
The purpose of the research study is to examine the effects of shortened sleep on blood pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2026
CompletedFirst Submitted
Initial submission to the registry
March 15, 2026
CompletedFirst Posted
Study publicly available on registry
March 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2027
March 24, 2026
March 1, 2026
1.4 years
March 15, 2026
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood Pressure
Blood pressure
Baseline and during the last 1-minute of stress
Study Arms (2)
Sleep Restriction
EXPERIMENTALYou will be asked to shorten your sleep to four hours.
Normal Sleep
NO INTERVENTIONYou will be asked to sleep for 7-9 hours.
Interventions
Eligibility Criteria
You may qualify if:
- Healthy adult men and women
- years of age
- BMI \< 25 kg/m² (normal weight group) or ≥ 30 kg/m² (obesity group)
- Non-pregnant, non-breastfeeding, and non-nicotine users
- Self-reported history of normal sleep duration (7-9 hours/night) and bedtime prior to midnight
- Premenopausal
You may not qualify if:
- No acute or chronic conditions
- Taking no medications known to affect sleep, autonomic, metabolic, or cardiovascular function
- Self-reported history of irregular sleep
- Self-reported history of hepatic, renal, pulmonary, cardiovascular, or neurological disease, stroke or neurovascular disease, bleeding/clotting disorders, sleep apnea or other sleep disorders, diabetes, history of alcoholism or substance abuse, major cardiovascular event or surgical procedure within the past three months, or hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Missouri
Columbia, Missouri, 65211, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 15, 2026
First Posted
March 24, 2026
Study Start
March 4, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
March 24, 2026
Record last verified: 2026-03